Key terms

About GSK

GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest GSK news

Yesterday 11:30am ET Trump Trade: Trump Media considers developing crypto payment service by TipRanks Yesterday 9:50am ET Trump expected to pick Martin Makary to head FDA, Reuters reports by TipRanks Yesterday 6:40am ET GSK announces Japan’s MHLW approved application to extend indication of Arexvy by TipRanks Nov 21 8:11am ET Science 37 nearly doubles U.S. enrollment for GSK Phase 3 rare disease trial by TipRanks Nov 19 6:25am ET GSK announces phase III trial of linerixibat met primary endpoint by TipRanks Nov 15 12:00pm ET Berkshire reveals stake in Domino’s, Alibaba reports mixed Q2: Morning Buzz by TipRanks Nov 15 5:00am ET Deutsche downgrades GSK to Hold on Trump’s RFK nomination by TipRanks Nov 15 4:40am ET GSK downgraded to Hold from Buy at Deutsche Bank by TipRanks Nov 14 4:35pm ET Vaccine makers fall after Trump nominates RFK to head HHS by TipRanks Nov 14 4:26pm ET Trump names Robert Kennedy as Secretary of Health and Human Services by TipRanks Nov 14 6:27am ET GlaxoSmithKline (GSK) Gets a Hold from Goldman Sachs by TipRanks Nov 14 6:22am ET GSK announces Blenrep met key secondary endpoint in DREAMM-7 trial by TipRanks Nov 13 12:01pm ET Reporters tweets about ‘vague whispers’ of bid interest in TG Therapeutics by TipRanks Nov 12 4:25am ET GSK downgraded to Hold from Buy at Jefferies by TipRanks Nov 12 1:05am ET GlaxoSmithKline (GSK) was downgraded to a Hold Rating at Jefferies by TipRanks Nov 11 4:35pm ET JMP Securities healthcare analysts hold an analyst/industry conference call by TipRanks Nov 11 12:06pm ET Cigna drops pursuit of Humana: Morning Buzz by TipRanks Nov 11 10:00am ET GSK to quit lobbying group BIO, STAT reports by TipRanks Nov 10 4:55am ET Ex-Dividend Date Nearing for These 10 Stocks – Week of November 11, 2024 by TipRanks Nov 08 2:35pm ET GSK price target lowered to 1,450 GBp from 1,550 GBp at Barclays by TipRanks Nov 08 1:35am ET Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK) by TipRanks Nov 05 12:55pm ET GSK Pharma put volume heavy and directionally bearish by TipRanks Nov 01 11:47am ET GlaxoSmithKline Updates Share Capital and Voting Rights by TipRanks Nov 01 3:16am ET Barclays Sticks to Their Hold Rating for GlaxoSmithKline (GSK) by TipRanks Oct 31 9:47pm ET GlaxoSmithKline (GSK) Receives a Hold from Kepler Capital by TipRanks Oct 31 3:00pm ET GSK price target lowered to 1,440 GBp from 1,550 GBp at JPMorgan by TipRanks Oct 31 2:01pm ET GSK price target lowered to 1,700 GBp from 1,850 GBp at Deutsche Bank by TipRanks Oct 31 9:28am ET Deutsche Bank Sticks to Their Buy Rating for GlaxoSmithKline (GSK) by TipRanks Oct 31 5:05am ET GSK downgraded to Neutral from Buy at Guggenheim by TipRanks Oct 31 12:29am ET GlaxoSmithKline Reports Mixed Q3 2024 Results by TipRanks Oct 30 9:36am ET Goldman Sachs Sticks to Its Hold Rating for GlaxoSmithKline (GSK) by TipRanks
Nov 20 11:00am ET GSK Drug for Rare Disease-Related Itch Meets Goal in Phase III Study by Zacks Nov 19 1:54pm ET Incyte Pauses Enrollment in Chronic Spontaneous Urticaria Study by Zacks Nov 07 11:13am ET Gilead Beats on Q3 Earnings and Sales, Raises Annual Outlook by Zacks Nov 05 8:28am ET Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings? by Zacks Oct 30 2:05pm ET GSK Q3 Earnings Top, Stock Down on Lowered '24 View for Vaccine Sales by Zacks Oct 30 9:05am ET GSK (GSK) Q3 Earnings Surpass Estimates by Zacks Oct 25 10:00am ET Earnings Preview: Editas Medicine (EDIT) Q3 Earnings Expected to Decline by Zacks Oct 23 11:33am ET PFE Gets FDA Nod for Expanded Use of RSV Vaccine Abrysvo by Zacks Oct 23 10:02am ET Analysts Estimate GSK (GSK) to Report a Decline in Earnings: What to Look Out for by Zacks Oct 21 1:50pm ET Gilead, MRK Report Data From Investigational Combination Study for HIV by Zacks Oct 21 11:32am ET Sanofi Negotiating Exclusively With CD&R for Opella 50% Stake Sale by Zacks

GSK Financials

1-year income & revenue

Key terms

GSK Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

GSK Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

Target expects a sluggish holiday season.
David Paul Morris/Bloomberg/Getty Images
Target sounds the alarm bell on holiday shopping
Investors piled into safe havens like gold and US debt as tensions rose in Europe. Gold prices jumped on Tuesday and US Treasury rates dipped.
Angela Weiss/AFP/Getty Images
Stocks shrug off concerns about heightened US-Russia tensions
A lone shopper places items in her cart in the frozen food aisle of a Walmart store Thursday, Nov. 14, 2024, in Englewood, Colo.
David Zalubowski/AP
As Americans bargain shop, six-figure earners flock to Walmart
NEW YORK, NEW YORK - JULY 07: Bikes with Grubhub bags sit on the street on July 07, 2023 in New York City. Grubhub, DoorDash and Uber Eats sued the City of New York on July 6th in order to block its new minimum pay rules for food delivery workers. (Photo by Leonardo Munoz/VIEWpress)
Leonardo Munoz/VIEWpress/Getty Images
Grubhub just sold for $650 million. Four years ago it was worth $7.3 billion